Sourcefire, Inc. – Trademark Portfolio
Entity Type: 03
Sourcefire, Inc. holds 32 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 27 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include SNORT, CLAMAV, and IMMUNET. The owner is based in Columbia, MD.
9770 Patuxent Woods Drive
Columbia, MD 21046
Showing of trademarks Trademarks
Trademark Classifications
Sourcefire, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Sourcefire, Inc. have?
Sourcefire, Inc. has 32 U.S. trademarks filed with the USPTO. Of these, 5 registered, 10 abandoned, 17 cancelled.
What trademark classes does Sourcefire, Inc. file in?
Sourcefire, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Sourcefire, Inc.'s most well-known trademarks?
Sourcefire, Inc.'s registered trademark portfolio includes well-known marks such as SNORT, CLAMAV, and IMMUNET. These are among 5 currently registered trademarks in the portfolio.
What is Sourcefire, Inc.'s trademark registration success rate?
Sourcefire, Inc. has a 16% trademark registration rate, with 5 out of 32 resolved applications resulting in successful registration. Currently, 0 applications are pending review.